entinostat has been researched along with Chronic Pancreatitis in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pancreatitis is a common inflammation of the pancreas with rising incidence in many countries." | 1.46 | Class I histone deacetylase inhibition improves pancreatitis outcome by limiting leukocyte recruitment and acinar-to-ductal metaplasia. ( Bombardo, M; Chen, R; Graf, R; Haumaitre, C; Malagola, E; Quilichini, E; Reding, T; Saponara, E; Seleznik, GM; Sonda, S; Zabel, A, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bombardo, M | 1 |
| Saponara, E | 1 |
| Malagola, E | 1 |
| Chen, R | 1 |
| Seleznik, GM | 1 |
| Haumaitre, C | 1 |
| Quilichini, E | 1 |
| Zabel, A | 1 |
| Reding, T | 1 |
| Graf, R | 1 |
| Sonda, S | 1 |
1 other study available for entinostat and Chronic Pancreatitis
| Article | Year |
|---|---|
Class I histone deacetylase inhibition improves pancreatitis outcome by limiting leukocyte recruitment and acinar-to-ductal metaplasia.
Topics: Acinar Cells; Acute Disease; Animals; Autoimmune Diseases; Benzamides; Disease Models, Animal; ErbB | 2017 |